Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amikacin-embedded humidifier for prevention of ventilator circuit colonization and early ventilator-associated pneumonia
PACTR202202537632410Completed
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of amikacin in ventilator-associated pneumonia (VAP) (2 arms). Primary endpoint: Effect of amikacin-embedded heated water bath humidifier on prevention of ventilator circuit colonization and ventilator-associated pneumonia. Started Mar 2022; status: completed.
02
Drugs
amikacin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on PACTR202202537632410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202537632410.